Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.400
+0.120 (9.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Apyx Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 48.54 | 52.35 | 44.51 | 48.52 | 27.71 | 28.24 | Upgrade
|
| Revenue Growth (YoY) | -3.49% | 17.61% | -8.26% | 75.08% | -1.86% | 70.04% | Upgrade
|
| Cost of Revenue | 19.22 | 18.59 | 15.38 | 14.92 | 10.21 | 9.14 | Upgrade
|
| Gross Profit | 29.33 | 33.76 | 29.13 | 33.6 | 17.5 | 19.09 | Upgrade
|
| Selling, General & Admin | 45.88 | 48.62 | 47.9 | 43.73 | 33.67 | 35.23 | Upgrade
|
| Research & Development | 4.77 | 4.84 | 4.54 | 4.32 | 3.92 | 3.73 | Upgrade
|
| Operating Expenses | 50.65 | 53.46 | 52.44 | 48.05 | 37.59 | 38.96 | Upgrade
|
| Operating Income | -21.32 | -19.7 | -23.31 | -14.45 | -20.08 | -19.87 | Upgrade
|
| Interest Expense | -5.37 | -2.48 | -0.02 | -0.01 | -0.05 | -0.01 | Upgrade
|
| Interest & Investment Income | 1.76 | 0.92 | 0.16 | 0.01 | 0.24 | 1.39 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0.62 | 0.51 | -0.37 | 0.48 | -0.35 | Upgrade
|
| EBT Excluding Unusual Items | -24.94 | -20.64 | -22.66 | -14.82 | -19.41 | -18.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 2.69 | - | - | - | - | Upgrade
|
| Legal Settlements | -0.25 | -0.25 | -0.25 | - | - | -1 | Upgrade
|
| Other Unusual Items | -3.09 | -3.09 | - | - | - | - | Upgrade
|
| Pretax Income | -28.27 | -21.28 | -22.91 | -14.82 | -19.41 | -19.84 | Upgrade
|
| Income Tax Expense | 0.25 | -2.43 | 0.37 | 0.38 | -7.5 | -0.13 | Upgrade
|
| Earnings From Continuing Operations | -28.52 | -18.85 | -23.28 | -15.2 | -11.91 | -19.71 | Upgrade
|
| Net Income to Company | -28.52 | -18.85 | -23.28 | -15.2 | -11.91 | -19.71 | Upgrade
|
| Minority Interest in Earnings | 0.08 | 0.14 | 0.09 | 0.03 | 0.01 | - | Upgrade
|
| Net Income | -28.44 | -18.71 | -23.18 | -15.17 | -11.9 | -19.71 | Upgrade
|
| Net Income to Common | -28.44 | -18.71 | -23.18 | -15.17 | -11.9 | -19.71 | Upgrade
|
| Shares Outstanding (Basic) | 35 | 35 | 35 | 34 | 34 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 35 | 35 | 34 | 34 | 34 | Upgrade
|
| Shares Change (YoY) | 0.10% | 0.31% | 0.54% | 0.35% | 0.42% | 2.66% | Upgrade
|
| EPS (Basic) | -0.82 | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | Upgrade
|
| EPS (Diluted) | -0.82 | -0.54 | -0.67 | -0.44 | -0.35 | -0.58 | Upgrade
|
| Free Cash Flow | -17.89 | -5.78 | -21.29 | -11.17 | -16.65 | -19.78 | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.17 | -0.62 | -0.33 | -0.49 | -0.58 | Upgrade
|
| Gross Margin | 60.41% | 64.49% | 65.45% | 69.26% | 63.17% | 67.63% | Upgrade
|
| Operating Margin | -43.93% | -37.63% | -52.37% | -29.78% | -72.47% | -70.37% | Upgrade
|
| Profit Margin | -58.59% | -35.75% | -52.09% | -31.27% | -42.93% | -69.79% | Upgrade
|
| Free Cash Flow Margin | -36.86% | -11.05% | -47.83% | -23.03% | -60.07% | -70.04% | Upgrade
|
| EBITDA | -20.71 | -19.01 | -22.42 | -13.55 | -19.2 | -19.12 | Upgrade
|
| EBITDA Margin | -42.67% | -36.31% | -50.38% | -27.92% | -69.27% | -67.70% | Upgrade
|
| D&A For EBITDA | 0.61 | 0.69 | 0.89 | 0.9 | 0.89 | 0.75 | Upgrade
|
| EBIT | -21.32 | -19.7 | -23.31 | -14.45 | -20.08 | -19.87 | Upgrade
|
| EBIT Margin | -43.93% | -37.63% | -52.37% | -29.78% | -72.47% | -70.37% | Upgrade
|
| Advertising Expenses | - | 1.8 | 2.3 | 1.3 | 0.8 | 1.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.